Dr. Laughren is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4709 Kemper St
Rockville, MD 20853Phone+1 301-871-3809
Education & Training
University of Wisconsin Hospitals and ClinicsResidency, Psychiatry, 1971 - 1974
University of Wisconsin School of Medicine & Public HealthClass of 1971
Certifications & Licensure
MD State Medical License 1984 - 2026
WI State Medical License 1972 - 2025- American Board of Psychiatry and Neurology Psychiatry
Publications & Presentations
PubMed
- 96 citationsA Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials.Luca Sforzini, Courtney Worrell, Melisa Kose, Ian M Anderson, Bruno Aouizerate
Molecular Psychiatry. 2022-03-01 - 8 citationsImpact of Obesity on Brexpiprazole Pharmacokinetics: Proposal for Improved Initiation of TreatmentChristopher D. Bruno, Ahmed Elmokadem, Conrad Housand, Eric Burroughs Jordie, Christina R. Chow
Journal of Clinical Pharmacology. 2021-08-26 - 1 citationsA Growing Crisis in Schizophrenia Drug Development: Failing Signal Detection at North American and Other Clinical Trial SitesThomas P. Laughren
The Journal of Clinical Psychiatry. 2020-03-03
Press Mentions
ABVC BioPharma Provides 2023 Pipeline UpdateFebruary 28th, 2023- PharmaTher : Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs AdvisorSeptember 29th, 2021
- PharmaTher Retains Former FDA Psychiatry Division Director Dr. Thomas Laughren as Regulatory Affairs AdvisorSeptember 29th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
